NL-OMON47479已完成不适用
CareMore study 1: prognostic value of HER2-positive circulating tumor cells in metastatic breast cancer patients treated with aromatase inhibitors (CareMore-AI study) - CareMore-AI
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational invasive
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •- Female patient with metastatic breast cancer
- •- Age >= 18 years
- •- Written informed consent
排除标准
- •- Adjuvant chemotherapy within 6 months prior to treatment start
- •- Other anticancer chemotherapy, use of biological response modifiers, or
- •immunotherapy within two weeks prior to treatment start. Hormonal antitumor
- •treatment within one week prior to treatment start.
- •- Serious illness or medical unstable condition prohibiting adequate treatment
- •and follow-up
研究者
相似试验
已完成
不适用
Prognostic value of HER2-positive circulating tumor cells in metastatic breast cancer patients treated with aromatase inhibitors<p>Breast cancer, borstkanker, HER2, ER, PIK3CA, CTC, circulating tumor cell, circulerende tumorcellen, metastasen, metastasis, AI, aromatase inhibitor, letrozole, anastrozole, arimidex, aromataseremmer</p>10006232NL-OMON24808Erasmus MC Cancer InstituteDepartment of Medical Oncology18
已完成
不适用
Prognostic significance of HER2 expression in patients with resectable gastric cancerGastric adenocarcinomaCancerISRCTN54802594Inje University Busan Paik Hospital782
已完成
不适用
Correlation between Prognosis and HER2 status in Advanced/Recurrent Gastric Cancer: Multicenter Retrospective AnalysisAdvanced/Recurrent Gastric CancerJPRN-UMIN000006451ational Cancer Center Hospital East300
招募中
1 期
Phase I clinical study on the safety of HER2-specific chimeric antigen receptor (CAR) gene-modified T cell therapyHER2 positive osteosarcoma/soft tissue sarcoma and gynecologic malignancyJPRN-jRCT2033220088Yozo Nakazawa12
尚未招募
2 期
Clinical Trial of Eribulin in Combination with Anrotinib for HER-2 Negative Locally Advanced or Metastatic Breast CancerBreast CancerNCT06678230The First Hospital of Jilin University40
